Author

M. A. Shields

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:development & morphogenesis· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. Spaulding· 2 shared H. G. Munshi· 2 shared T. N. Pham· 2 shared A. E. Metropulos· 1 shared M. G. Khalafalla· 1 shared S. Ohno· 1 shared T. Hirose· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

C. Spaulding

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BET inhibition rescues ciliogenesis and ameliorates pancreatitis-driven phenotypic changes in mice with Par3 loss.

M. A. Shields, A. E. Metropulos, C. Spaulding, T. Hirose, S. Ohno, T. N. Pham, H. G. Munshi

This study shows that BET inhibition rescues ciliogenesis and reduces pancreatitis-induced damage in mice with Par3 loss.

bioRxiv · Sep 14, 2023 · PreprintPathology

Gα13 loss promotes tumor progression in the KPC transgenic mouse model of advanced pancreatic cancer

M. A. Shields, C. Spaulding, M. G. Khalafalla, T. N. Pham, H. G. Munshi

The paper shows that Gα13 loss promotes tumor progression in the KPC mouse model of advanced pancreatic cancer but not in the KC model, with increased tumor burden and reduced survival.

bioRxiv · Mar 15, 2021Cancer Biology